ByteBrief

Best read upright.

We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.

(We tried widescreen once. It wasn't us.)

ByteBrief

AIFinancial Timesabout 1 hour ago

Monod Bio Licenses AI Proteins to SignalChem

1 min read

Monod Bio licensed AI-designed protein technologies to SignalChem Biotech for custom discovery assays. The deal brings Monod's engineered proteins into SignalChem's assay development pipeline. Financial terms were not disclosed.

Level

Hype check

Tap to vote and see what everyone thinks.

#monod bio #signalchem biotech #protein design

Read full story

More to chew on!

AI5 days ago

AI drug discovery raises patent credit questions

AI7 days ago

Vivodyne Opens Human Data Center for AI Drug Testing

AI5 days ago

AI Is Learning to Write Genetic Code

Summary by ByteBrief